share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

諾瓦瓦克斯醫藥 | 4:持股變動聲明-董事 YOUNG JAMES F
美股SEC公告 ·  01/02 13:46

Moomoo AI 已提取核心訊息

James F. Young, an insider at Novavax, has planned to sell a total of 10,000 shares of common stock in two transactions. The first sale of 4,600 shares is scheduled for 12/24/2024 at $8.48 per share, followed by a second sale of 5,400 shares on 12/31/2024 at $8.00 per share.The total market value of the disposed shares amounts to $82,208. After these transactions, Young's remaining direct ownership in Novavax will be 51,760 shares. Both sales are classified as open market or private sales.These planned transactions indicate a reduction in Young's stake in Novavax, with the sales occurring at slightly different price points over a week-long period. The company has not provided any additional context for these insider sales.
James F. Young, an insider at Novavax, has planned to sell a total of 10,000 shares of common stock in two transactions. The first sale of 4,600 shares is scheduled for 12/24/2024 at $8.48 per share, followed by a second sale of 5,400 shares on 12/31/2024 at $8.00 per share.The total market value of the disposed shares amounts to $82,208. After these transactions, Young's remaining direct ownership in Novavax will be 51,760 shares. Both sales are classified as open market or private sales.These planned transactions indicate a reduction in Young's stake in Novavax, with the sales occurring at slightly different price points over a week-long period. The company has not provided any additional context for these insider sales.
諾瓦瓦克斯醫藥的內部人士詹姆斯·F·楊計劃分兩筆交易出售總計10,000股普通股。第一次出售4,600股定於2024年12月24日以每股8.48美元的價格進行,隨後在2024年12月31日出售5,400股,價格爲每股8.00美元。處置股票的總市場價值爲82,208美元。在這些交易後,楊在諾瓦瓦克斯醫藥的剩餘直接持股爲51,760股。兩筆銷售均被歸類爲公開市場或私人交易。這些計劃中的交易表明楊在諾瓦瓦克斯醫藥的股份減少,銷售在一週內略有不同的價格點進行。公司並未對此次內部銷售提供任何額外背景。
諾瓦瓦克斯醫藥的內部人士詹姆斯·F·楊計劃分兩筆交易出售總計10,000股普通股。第一次出售4,600股定於2024年12月24日以每股8.48美元的價格進行,隨後在2024年12月31日出售5,400股,價格爲每股8.00美元。處置股票的總市場價值爲82,208美元。在這些交易後,楊在諾瓦瓦克斯醫藥的剩餘直接持股爲51,760股。兩筆銷售均被歸類爲公開市場或私人交易。這些計劃中的交易表明楊在諾瓦瓦克斯醫藥的股份減少,銷售在一週內略有不同的價格點進行。公司並未對此次內部銷售提供任何額外背景。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息